Versor Investments’s Cidara Therapeutics CDTX Stock Holding History

Versor Investments’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-73,200	Closed	-$16.2M	–	130
2025 Q4	$16.2M	Buy	+73,200	New	+$11.8M	2.52%	3

Versor Investments's CDTX Position: Q1 2026 in Review

Versor Investments sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 73,200 shares — an estimated $16.2M sold.

Versor Investments first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $16.2M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Versor Investments reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Versor Investments sold 73,200 Cidara Therapeutics shares in Q1 2026, an estimated $16.2M.
Versor Investments first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Versor Investments's Cidara Therapeutics position peaked at $16.2M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.